Clinical Trial Update: A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen [Phase 3]

View source ↗

Summary

Phase 3 trial update for Olezarsen in adults with Familial chylomicronemia syndrome (FCS) who were previously treated with Volanesorsen; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Chylomicronemia Syndrome

Drugs mentioned

• Olezarsen (olezarsen)
• Volanesorsen (volanesorsen)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Familial Chylomicronemia Syndrome | Phase 3 | Status: ACTIVE_NOT_RECRUITING